Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Baricitinib |
Trade Name | Olumiant |
Synonyms | LY3009104|INCB028050|INCB 028050|LY 3009104 |
Drug Descriptions |
Baricitinib (LY3009104) is a selective inhibitor of JAK1, JAK2, and TYK2, which may decrease tumor cell viability (PMID: 20363976, PMID: 29399328, PMID: 29296813). |
DrugClasses | JAK1 Inhibitor - ATP competitive 5 JAK2 Inhibitor - ATP competitive 15 |
CAS Registry Number | 1187594-09-7 |
NCIT ID | C127012 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Baricitinib | Baricitinib | 4 | 0 |